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Schmitt et al. suggest that Th1
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strongly inhibit the Tfh cell differentiation
program per se but diminishes the helper
functions of developing Tfh cells. IRF4
seems important in tipping the balance of
Tfh and Th1 differentiation toward Tfh at
early stages.
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IL-12 is important for the differentiation of T follicular
helper (Tfh) cells, as well as Th1 cells in humans. Still,
how IL-12 signals regulate Tfh versus Th1 cell differ-
entiation remains poorly characterized. Here we
aimed to determine the molecular mechanisms that
regulate the differentiation and the function of IL-
12-stimulated human naive CD4+ T cells. We found
that T-bet promoted the expression of CXCR5 in hu-
man CD4+ T cells. We provide evidence that T-bet
does not strongly inhibit the Tfh cell differentiation
program per se but diminishes the functions to pro-
vide help to B cells. This study also suggests that
IRF4 plays an important role in driving the early differ-
entiation of IL-12-stimulated CD4+ T cells toward Tfh
and away from Th1 by inhibiting the expression of
Eomesodermin. Thus, the fate of IL-12-stimulated
CD4+ T cells is determined through interplay of mul-
tiple transcription factors at early stages.INTRODUCTION
Studies in the past decade have established T follicular helper
(Tfh) cells as the major CD4+ T cell subset providing help to
B cells and promoting antibody responses (Crotty, 2014; Ma
et al., 2012; Ueno et al., 2015). Tfh cells are essential for the
formation of germinal centers (GCs), the site for the selection
of high-affinity B cells and for the development of B cell memory
(MacLennan, 1994; Vinuesa and Cyster, 2011). Tfh cells and their
precursors are equippedwithmultiple features required for B cell
help (Crotty, 2014; Ma et al., 2012; Ueno et al., 2015). Interleukin
(IL) 21 secreted by Tfh cells potently promotes the growth, differ-
entiation, and class-switching of B cells. Tfh cells in GCs express
high levels of inducible co-stimulator (ICOS), a cell surface co-
stimulatory molecule crucial for Tfh cell interactions with B cells.
CD40 ligand (CD40L) expressed by Tfh cells provides signals to
B cells through CD40 for their differentiation and class-switch-
ing. Tfh cell differentiation requires the expression of the tran-1082 Cell Reports 16, 1082–1095, July 26, 2016 ª 2016 The Authors
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is suppressed by the transcription repressor B lymphocyte-
induced maturation protein 1 (Blimp-1), a Bcl-6 antagonist.
Whether naive CD4+ T cells commit to differentiate into the Tfh
lineage is largely pre-determined during the first step, in which
CD4+ helper T cells are primed by dendritic cells (DCs) (Vinuesa
and Cyster, 2011). Upon interactions with antigen-presenting
DCs, a fraction of CD4+ T cells upregulate the expression of che-
mokine receptor CXCR5 while downregulating CCR7 expres-
sion, partly through the upregulated expression of the transcrip-
tion factors (TFs) Bcl-6 and Ascl2 (Baumjohann et al., 2011; Choi
et al., 2011; Kerfoot et al., 2011; Kitano et al., 2011; Liu et al.,
2012, 2014). Such changes in the chemokine receptor expres-
sion promote the migration of activated CD4+ T cells toward
B cell follicles and interactions with B cells at the T-B border.
Tfh precursors then increase Bcl-6 expression and eventually
differentiate into mature Tfh cells (Vinuesa and Cyster, 2011).
In humans, IL-12 secreted by DCs plays an important role dur-
ing the first differentiation step. Among DC-derived cytokines,
IL-12 is the most efficient at inducing human naive CD4+
T cells to express Tfh molecules, including CXCR5, ICOS, and
IL-21, and to upregulate TFs important for Tfh cell differentiation,
such as Bcl-6, Batf, and c-Maf (Ma et al., 2009; Schmitt et al.,
2009, 2013, 2014). Children who lack the expression of a func-
tional IL-12 receptor b1 chain display fewer CXCR5+ circulating
Tfh (cTfh) cells and memory B cells, indicating that signaling
through the IL-12 receptor is important for the development
and/or maintenance of human Tfh cells (Schmitt et al., 2013).
However, IL-12 signals also drive the differentiation program to-
ward the T helper 1 (Th1) cell through the upregulation of the TF
T-bet (Szabo et al., 2000). T-bet collaborates with STAT4 acti-
vated by IL-12 signals for the expression of interferon (IFN)-g
(Thieu et al., 2008). The produced IFN-g further provides a
positive feedback loop by enhancing T-bet expression through
STAT1 activation (Afkarian et al., 2002; Ylikoski et al., 2005).
The molecular mechanisms regulating the differentiation of
Th1 versus Tfh cells from IL-12-stimulated CD4+ T cells remain
largely uncharacterized in humans. This topic has been exten-
sively studied in mice (Weinmann, 2014), because IL-12 stimula-
tion promotes mouse naive CD4+ T cells to express both Tfh and
Th1molecules (Eto et al., 2011; Nakayamada et al., 2011). These.
creativecommons.org/licenses/by-nc-nd/4.0/).
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studies largely agree with the inhibitory role of T-bet in Tfh cell
differentiation. T-bet-deficient CD4+ T cells expressed higher
levels of CXCR5, IL-21, and Bcl-6 in response to IL-12 stimula-
tion in vitro, and T-bet-deficient mice showed enhanced Tfh
and GC response upon infection with Toxoplasma gondii (Na-
kayamada et al., 2011). T-bet was found to bind the promoter
regions of the murine Bcl6 gene and was suggested to directly
suppress Bcl-6 transcription (Nakayamada et al., 2011). T-bet
was also shown to inhibit the function of Bcl-6 by masking the
DNA-binding domain through the formation of a complex with
Bcl-6 (Oestreich et al., 2012). In contrast, Bcl-6 represses the
expression of T-bet (Nurieva et al., 2009; Yu et al., 2009). Thus,
whether a CD4+ T cell differentiates into a Th1 or a Tfh cell seems
largely regulated by the balance between T-bet andBcl-6 inmice
(Weinmann, 2014).
Whether this regulatory mechanism also operates in humans
remains to be established, because the dominant signal path-
ways promoting the expression of Tfh molecules seem different
between the two species (Ueno et al., 2015). For example,
although IL-12 is the most potent cytokine to induce human
naive CD4+ T cells to express IL-21 (Ma et al., 2009; Schmitt
et al., 2009, 2013), IL-6 and IL-21 are more potent than IL-12
in mouse naive CD4+ T cells (Suto et al., 2008). Furthermore,
whereas IL-12 stimulation induces CD4+ T cells stably express-
ing IL-21 in humans (Ma et al., 2009; Schmitt et al., 2009,
2013), IL-12-stimulated mouse CD (mCD)4+ T cells express
IL-21 only transiently (Nakayamada et al., 2011; Suto et al.,
2008). In addition, although the stimulation with type I IFNs
promotes the expression of Th1 molecules such as T-bet and
IFN-g in both mice and human CD4+ T cells, the expression
of Tfh molecule is totally different between the two species.
Type I IFNs promote the expression Bcl-6, CXCR5, and
PD-1, but not IL-21, in mCD4+ T cells (Nakayamada et al.,
2014). In contrast, type I IFNs suppress the expression of
Bcl-6, CXCR5, and ICOS but promote the expression of
Blimp-1 and IL-21 in human CD4+ T cells (Schmitt et al.,
2014; Wong et al., 2010).
In this study, we aimed to determine the molecular mecha-
nisms regulating the differentiation of Th1 versus Tfh cells in hu-
man CD4+ T cells. We show that T-bet does not strongly inhibit
the Tfh cell differentiation program per se in humans but inhibits
the helper functions of IL-12-stimulated CD4+ T cells. Our study
suggests that IRF4 serves as an important factor to tip the bal-
ance of differentiation of IL-12-stimulated CD4+ T cells toward
Tfh cells and away from Th1 cells in humans.Figure 1. IL-12 Induces CXCR5+ CD4+ T Cells Expressing Both Tfh and
(A) Human naive CD4+ T cells were stimulated with anti-CD3 and CD28 in the pres
21, and IFN-g (cytokines after 6 hr phorbol myristate acetate [PMA] and ionomyci
activated cells. Representative of five experiments.
(B) IL-12 titration. Naive CD4+ T cells were stimulated with titrated amounts of IL-1
is shown. Representative of three experiments.
(C) T-bet and Bcl-6 expression. Naive CD4+ T cells were cultured with the indicat
day 3. Gated to FSChiSSChi activated cells. Representative of four experiments.
(D) The kinetics of TF expression. Naive CD4+ T cells were stimulated with anti-C
CD4+ T cells were harvested at the indicated time points and analyzed for the e
housekeeping genes included in the code set. Mean ± SD, n = 3. Paired t test, *
(E) The kinetics of T-bet and Bcl-6 expression. The expression of T-bet and Bcl-6 b
three experiments.
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IL-12-Induced CXCR5+ CD4+ T Cells Express Both Tfh
and Th1 Molecules
We stimulated human naive CD4+ T cells with anti-CD3 and anti-
CD28 in the presence of titrated amounts of IL-12, and we
analyzed the expression of CXCR5, together with Tfh and Th1
molecules. IL-12 dose-dependently promoted CXCR5 expres-
sion on activated CD4+ T cells, and the induced CXCR5+ CD4+
T cells expressed both Tfh molecules (ICOS, CD40L, and
IL-21) and Th1 molecules (IFN-g and T-bet) (Figures 1A–1C).
Although IL-12 stimulation did not strongly induce the expres-
sion of the Bcl-6 protein (Schmitt et al., 2013), the stimulation
with IL-12+IL-1b+IL-6+transforming growth factor b (TGF-b),
one of the cytokine combinations that strongly promote the hu-
man CD4+ T cell differentiation program toward the Tfh lineage
(Schmitt et al., 2014; Schmitt and Ueno, 2015), induced
CXCR5+ CD4+ T cells highly expressing Bcl-6 (Figure 1C).
The kinetics of the expression of TFs by IL-12-stimulated
human CD4+ T cells was first determined by Nanostring. IL-12
stimulation increased the expression of TBX21 (encoding
T-bet), BCL6, and BATF as early as within 1 day and the expres-
sion ofMAF on day 2, but it did not largely affect the expression
of PRDM1 (encoding Blimp-1) or IRF4 (Figure 1D). While TBX21
expression peaked on day 1 after IL-12 stimulation, BCL6
expression peaked on day 3. The analysis of the kinetics of
TF expression by flow cytometry showed that T-bet expression
by human naive CD4+ T cells stimulated with IL-12 and IL-
12+IL-1b+IL-6+TGF-b rapidly decreased after day 3 and that
more than 60% of cells became negative on day 5 (Figure 1E).
Bcl-6 expression also decreased more on day 5 than on day 3.
Thus, the expression of T-bet and Bcl-6 is not stable in cyto-
kine-stimulated human naive CD4+ T cells.
T-bet Overexpression Enhanced CXCR5 Expression
To examine whether constitutive T-bet expression affects the
expression of Tfh molecules, T-bet expression HIV-derived vec-
tor (HDV, subcloned with the murine Cd24 gene into the vector)
(Sundrud et al., 2003) was transfected into human naive CD4+
T cells (Figure 2A). The phenotype of the transfected cells was
analyzed with flow cytometry by gating to the cells expressing
mCD24. To our surprise, T-bet overexpression promoted
CXCR5 expression by CD4+ T cells and resulted in increased
generation of CXCR5+CCR7 cells (Figure 2B), a chemokine
receptor expression pattern required for the migration towardTh1 Molecules
ence or absence of IL-12 for 3 days. The expression of CD40L, ICOS, CCR7, IL-
n re-stimulation), together with CXCR5, was determined. Gated to FSChiSSChi
2. The percentage of the indicated phenotype within FSChiSSChi activated cells
ed cytokines, and the expression of CXCR5, T-bet, and Bcl-6 was analyzed on
D3 and CD28, and IL-12 was added to the culture after overnight stimulation.
xpression of TF transcripts by Nanostring. Data were normalized with seven
p < 0.05, **p < 0.01.
y activated CD4+ T cells was analyzed on the days indicated. Representative of
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Figure 2. T-bet Overexpression Increases CXCR5 Expression
(A) T-bet expression by T-bet HDV-transfected human naive CD4+ T cells. Both control and T-bet HDV contain the mCd24 gene.
(B) CXCR5 and CCR7 expression by T-bet HDV-transfected CD4+ T cells stimulated with anti-CD3 and CD28 without additional cytokines. Gated to mCD24+
cells. A representative of eight experiments is shown in the left panel. The percentage of CXCR5+ and CXCR5+CCR7 cells within mCD24+ cells is indicated in the
right panels. n = 8. Paired t test, ***p < 0.001.
(C) CXCR5 transcript expression by T-bet HDV- and control HDV-transfected CD4+ T cells analyzed by Nanostring. n = 3. Paired t test, *p < 0.05.
(D) CXCR5 expression by carboxyfluorescein succinimidyl ester (CFSE)-labeled CD4+ T cells transfected with T-bet HDV or control HDV.
(E) CXCR5 and CCR7 expression by activated T-bet HDV-transfected CD4+ T cells stimulated with IL-12 for 48 hr. Gated to mCD24+ cells. A representative of
eight experiments is shown in the left panel. The percentage of CXCR5+ andCXCR5+CCR7 cells withinmCD24+ cells is indicated in the right panels. n = 8. Paired
t test, ***p < 0.001.
(F) T-bet ChIP assay. T-bet bound to a promoter region of the CXCR5 gene. IFNG was used as a positive control, and IGX1 andMYOD1 were used as negative
controls. Mean ± SEM, n = 4.B cell follicles (Haynes et al., 2007). T-bet overexpression also
increased the expression of CXCR5 transcript by activated
naive CD4+ T cells (Figure 2C), and the increased CXCR5 by
T-bet overexpression was independent of cell division numbers
(Figure 2D; Figure S1). T-bet overexpression also promoted
CXCR5 expression by CD4+ T cells stimulated with IL-12 (Fig-
ure 2E). To determine whether T-bet directly regulates CXCR5
expression, we performed T-bet chromatin immunoprecipitation
(ChIP) assay with IL-12-stimulated CD4+ T cells. We found that
T-bet substantially bound to the CXCR5 gene, as well as to apositive-control IFNG gene (Figure 2F). These results show that
T-bet promotes the expression of CXCR5 in activated human
CD4+ T cells.
T-bet Downregulates EBI2 Expression
EBI2 is a receptor regulating the positioning of lymphocytes in
secondary lymphoid organs (Vinuesa and Cyster, 2011). The
EBI2 ligand 7a,25-dihydroxycholesterol is highly expressed by
lymphoid stromal cells at the follicle perimeter (Yi et al., 2012),
and B cells and T cells need to downregulate EBI2 to remain inCell Reports 16, 1082–1095, July 26, 2016 1085
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Downregulation
(A) GPR183 expression by tonsillar GC Tfh cells.
Tonsillar naive CD4+ T cells (CD45RA+CXCR5
ICOS) and GC Tfh cells (CXCR5hiICOShi) were
analyzed for the expression of GPR183 with
Nanostring.
(B) The kinetics of GPR183 expression. Naive CD4+
T cells were stimulated with anti-CD3 and CD28, and
IL-12 was added to the culture after overnight incu-
bation. CD4+ T cells were harvested at the indicated
time points, and analyzed for the expression of
GPR183. Mean ± SD, n = 3. Paired t test, **p < 0.01,
*p < 0.05.
(C) GPR183 expression by activated naive CD4+
T cells stimulated with different cytokines for 48 hr.
Mean ± SD, n = 3. IL-12 stimulation significantly
decreased GPR183 expression compared to stimu-
lation with the other cytokines, except IL-6. One-way
ANOVA, ***p < 0.001.
(D) STAT4 and T-bet inhibit downregulation of
GPR183 by IL-12-stimulated CD4+ T cells. Naive
CD4+ T cells were transfected with the indicated
siRNA and then cultured with or without IL-12 for
48 hr. Mean ± SD, n = 3. One-way ANOVA, *p < 0.05,
***p < 0.001.
(E) T-bet suppresses GPR183 expression. GPR183
expression by naive CD4+ T cells transfected with
either control HDV or T-bet HDV was analyzed. The
mCD24+ cells were sorted to isolate HDV-transfected
cells. n = 4. Paired t test, ***p < 0.001.the follicular center (Hannedouche et al., 2011; Liu et al., 2011;
Suan et al., 2015). We confirmed that human tonsillar GC Tfh
cells expressed lower levels of EBI2 (encoded by GPR183)
than do tonsillar naive CD4+ T cells (Figure 3A). A kinetics study
showed that EBI2 expression rapidly decreased (within a day)
in naive CD4+ T cells after CD3-CD28 stimulation but then
transiently increased (Figure 3B). However, IL-12 stimulation
inhibited this transient increase and progressively promoted
its downregulation. We wondered whether other cytokines also
affect the expression of EBI2 by activated human CD4+ T cells.
CD3- and CD28-stimulated naive CD4+ T cells were cultured
for 2 days in the presence of different cytokines, and EBI2
expression was analyzed. Among the tested cytokines, IL-12
was the most potent at inhibiting EBI2 re-expression (Figure 3C).
Inhibition of STAT4 and T-bet expression by transfecting a spe-
cific small interfering RNA (siRNA) (Figure S2) (Schmitt et al.,
2009) partially reverted the downregulation of EBI2 by IL-12 stim-1086 Cell Reports 16, 1082–1095, July 26, 2016ulation (Figure 3D). Yet, the effect on EBI2
expression by T-bet inhibition was minimal,
suggesting that other molecules such as
STAT4 were dominant in suppressing EBI2
at this time point. The effect of STAT4 siRNA
transfection on EBI2 expression might also
be underappreciated in this experiment,
because the effect of STAT4 siRNA is short
lived, particularly when CD4+ T cells are
stimulated with IL-12 (Schmitt et al., 2009).
Nonetheless, T-bet overexpression potentlysuppressed EBI2 in both control CD4+ T cells and IL-12-stimu-
lated CD4+ T cells (Figure 3E). EBI2 downregulation by IL-12
was independent of the IFN-g-STAT1 axis, because IFN-g stim-
ulation (Figure 3C) or STAT1 siRNA transfection (Figure 3D) did
not affect EBI2 expression. Thus, these results suggest that
STAT4 and T-bet promote the downregulation of EBI2 expres-
sion. Collectively, these results show that T-bet contributes to
upregulation of CXCR5 while downregulating CCR7 and EBI2
and thus to acquisition of the phenotype promoting themigration
toward and the retention within B cell follicles.
Tfh-Related TFs Are Regulated Differently by T-bet
TodeterminehowT-bet regulates theexpressionofTfhgenes,we
transfected T-bet HDV or control HDV to activated human naive
CD4+ T cells and compared the gene profiles. T-bet overexpres-
siondecreased theexpressionofBCL6and increased theexpres-
sion of PRDM1 (Figure 4A). However, T-bet overexpression
A CB
D
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E
Figure 4. T-bet Does Not Inhibit Bcl-6 Expression in Human CD4+ T Cells
(A) Gene profiling of activated naive CD4+ T cells transfected with either control HDV or T-bet HDV and cultured without additional cytokines. Transcript counts in
T-bet HDV-transfected CD4+ T cells were normalized to those in control HDV-transfected CD4+ T cells in each donor. Results from three donors are shown.
(B) Gene profiling of activated naive CD4+ T cells transfected with either control siRNA or T-bet siRNA and stimulated with IL-12 for 48 hr. Transcript counts in
T-bet siRNA-transfected CD4+ T cells were normalized to those in control siRNA-transfected CD4+ T cells in each donor. Results from three donors are shown.
(legend continued on next page)
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increased the expression of other TFs that are required for Tfh
cell differentiation, such as MAF and BATF (Crotty, 2014), and
suppressed the expression of FOSL2, which inhibits Tfh differen-
tiation (Hu et al., 2014). In contrast, transfection of T-bet siRNA
increased theexpressionofBCL6andFOSL2by IL-12-stimulated
CD4+ T cells and decreased the expression of PRDM1, MAF,
and BATF (Figure 4B). Thus, T-bet regulates Tfh-related TFs
differently.
In mCD4+ T cells, T-bet was shown to repress Bcl-6 expres-
sion by directly binding to the Bcl6 gene (Nakayamada et al.,
2011). To examine whether this is conserved in humans, we per-
formed T-bet ChIP assay with IL-12-stimulated human CD4+
T cells and analyzed the binding to BCL6 and PRDM1 genes.
We found that T-bet bound to the BCL6 gene at one among
the tested four sites and to the PRDM1 gene at multiple sites
(Figure 4C; Figure S3A). These results suggest that T-bet directly
downregulates Bcl-6 and upregulates Blimp-1 in human CD4+
T cells. Nonetheless, because BCL6 and PRDM1 transcript
abundance does not always correlate with protein expression
in CD4+ T cells, we analyzed their expression by flow cytometry
and immunoblot. The analysis with flow cytometry showed that
T-bet overexpression did not inhibit Bcl-6 expression in acti-
vated CD4+ T cells, including those stimulated with Tfh-promot-
ing cytokine condition IL-23+IL-6+TGF-b (Figure S3B). The anal-
ysis with immunoblot also showed T-bet overexpression or T-bet
inhibition did not significantly affect Bcl-6 expression or Blimp-1
expression (Figures 4D and 4E). Thus, T-bet does not strongly
affect Bcl-6 or Blimp-1 expression in human CD4+ T cells.
Collectively, these results suggest that T-bet does not shut
off the Tfh cell differentiation program per se in human CD4+
T cells. This conclusion is in line with our previous observation
that a fraction of GC Tfh cells in humans tonsils co-express
Bcl-6 and T-bet (Schmitt et al., 2014). We further confirmed the
presence of T-bet+ Tfh cells in GCs in human tonsils by immuno-
fluorescent microscopy (Figure 4F).
T-bet Negatively Regulates Helper Functions
Transcript analyses showed that T-bet overexpression
decreased the expression of CD40LG and ICOS (Figures 4A
and 4B). This was also confirmed at a protein level (Figure 5A;
Figure S4A). Whereas T-bet overexpression increased the
CXCR5+ population (Figure 2B), the expression of CD40L and
ICOS within the CXCR5+ population decreased (Figure S4C).
Conversely, T-bet siRNA transfection increased the expression
of CD40L and ICOS transcripts (Figures 4A and 4B) and proteins
(Figure 5B; Figures S4B and S4D) by IL-12-stimulated CD4+
T cells. We further found that IL-21 expression by IL-12-stimu-
lated CD4+ T cells was substantially inhibited by T-bet overex-
pression yet enhanced by T-bet inhibition (Figures 5A and 5B;(C) T-bet ChIP assay. T-bet binds to thePRDM1 gene but not to theBCL6 gene. IFN
controls. Mean ± SEM, n = 4.
(D and E) Analysis of Bcl-6 and Blimp-1 expression by immunoblot. Activated naiv
the presence or absence of IL-12. The expression of Bcl-6 and Blimp-1 by sorted m
experiments. (E) The densitometry score ratio for Bcl-6 and Blimp-1 against contro
(control siRNA or HDV transfection, no IL-12). n = 3. Paired t test.
(F) T-bet+ GC Tfh cells in tonsils. Confocal microscopy of IgD (green), CD4 (blue)
T-bet+ GC Tfh cells (indicated by white arrows) are provided in the right panels.
1088 Cell Reports 16, 1082–1095, July 26, 2016Figures S4A–S4D). These results show that T-bet inhibits the
expression of CD40L, ICOS, and IL-21. T-bet ChIP assay re-
vealed that T-bet bound to CD40LG and IL21 genes (Figure 5C;
Figure S3A), suggesting the capacity to directly control their
expression.
Furthermore, to address the long-term effects of T-bet on the
expression of Tfh molecules, we sorted mCD24+ cells at day 3
after HDV transfection, cultured them for 3 additional days in
the same conditions, and analyzed their phenotype at day 6
after HDV transfection. We found that T-bet overexpression
enhanced CXCR5 expression while inhibiting the expression of
ICOS, CD40L, and IL-21 (Figure S4E). However, T-bet overex-
pression did not inhibit Bcl-6 expression (Figure S4E). These re-
sults show that T-bet decreases the expression of ICOS, CD40L,
and IL-21 while increasing the expression of CXCR5.
Given that CD40L, ICOS, and IL-21 play fundamental roles
when Tfh cells provide help to B cells, we hypothesized that
T-bet suppresses their helper functions. To this end, we
analyzed whether transfection of T-bet siRNA or T-bet HDV af-
fects the ability of activated CD4+ T cells to help B cells. Trans-
fected CD4+ T cells were stimulated in either the absence or
the presence of IL-12 and then co-cultured with autologous
B cells. The recovery and the phenotype of cultured B cells
were analyzed by flow cytometry. Consistent with previous
studies (Ma et al., 2009; Schmitt et al., 2009), IL-12-stimulated
CD4+ T cells transfected with control siRNA were able to induce
B cells to differentiate into CD20loCD138+ plasma cells (Fig-
ure 5D). Transfection of T-bet siRNA further enhanced the recov-
ery and the generation of plasma cells by IL-12-stimulated CD4+
T cells. Furthermore, IL-12-stimulated CD4+ T cells transfected
with T-bet siRNA induced B cells to produce the largest amounts
of immunoglobulins (Igs) (Figure S4F). In contrast, CD4+ T cells
transfected with T-bet HDV, even when stimulated with IL-12,
failed to maintain the survival of B cells (Figure 5E) or to induce
B cells to produce Igs (Figure S4G). Thus, T-bet downregulates
the helper functions of IL-12-stimulated activated CD4+ T cells.
CXCR5 Expression Is Inhibited by the IFN-g-STAT1 Axis
IL-12 stimulation induces human CD4+ T cells to express IFN-g,
which activates STAT1. Studies with mCD4+ T cells showed
that STAT1 signals both promote and inhibit Tfh cell differentia-
tion according to the context (Crotty, 2014). Thus, it is possible
that STAT1 contributes to the expression of Tfh cell molecules,
for example, CXCR5 in IL-12-stimulated human CD4+ T cells.
Therefore, we analyzed how STAT1 inhibition by transfecting a
specific siRNA affects the phenotype. STAT1 siRNA transfection
resulted in decreased STAT1 expression bymore than 80% (Fig-
ure S5A) but not in decreased expression of other STAT mole-
cules, including STAT3 and STAT4 (Figure S5B). STAT1 siRNAGwas used as a positive control, and IGX1 andMYOD1were used as negative
e CD4+ T cells transfected with the indicated reagents were cultured for 48 hr in
CD24+ CD4+ T cells was analyzed by immunoblot. (D) Representative of three
l GAPDH protein was determined and then normalized to the control condition
, and T-bet (red) in human tonsil sections. Higher-magnification images of two
FM, follicular mantle. Scale bar, 100 mm (left) and 10 mm (right).
A C
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Figure 5. T-bet Overexpression Abrogates the Helper Function of IL-12-Stimulated CD4+ T Cells
(A) Expression of ICOS, CD40L, and IL-21 (after PMA and ionomycin re-stimulation) by activated T-bet HDV-transfected CD4+ T cells after 48 hr stimulation with
IL-12. Gated to mCD24+ cells. Representative of nine experiments.
(B) Expression of ICOS, CD40L, and IL-21 (after PMA and ionomycin re-stimulation) by activated T-bet siRNA-transfected CD4+ T cells after 48 hr stimulation with
IL-12. Gated to FSChiSSChi activated cells. Representative of 12 experiments.
(legend continued on next page)
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Figure 6. STAT1 and IFN-g Inhibit CXCR5
Expression by IL-12-Stimulated CD4+
T Cells
(A and B) CXCR5 and CCR7 expression by STAT1
siRNA-transfected CD4+ T cells stimulated with
or without IL-12 for 48 hr. Gated to FSChiSSChi
activated cells. (A) Representative of nine experi-
ments. (B) The percentage of CXCR5+ and
CXCR5+CCR7 cells within FSChiSSChi activated
cells. n = 9. Paired t test, ***p < 0.001.
(C) CXCR5 and CCR7 expression by IL-12-stim-
ulated CD4+ T cells cultured in the presence
of anti-IFN-g and IFN-g receptor (IFN-gR). The
percentage of CXCR5+ and CXCR5+CCR7 cells
within FSChiSSChi activated cells. n = 6. Paired t
test, ***p < 0.001.transfection did not affect T-bet expression by IL-12-stimulated
CD4+ T cells in our culture system (Figure S5C) and therefore pro-
vided an opportunity to determine the role of STAT1 without the
impact of T-bet. We found that STAT1 inhibition increased the
expression of CXCR5 by IL-12-stimulated CD4+ T cells and
the generation of CXCR5+CCR7 cells (Figures 6A and 6B).
Consistently, blocking IFN-g with neutralizing monoclonal anti-
bodies (mAbs) also resulted in a moderate but substantial in-
crease of CXCR5 expression by IL-12-stimulated CD4+ T cells
(Figure 6C), even those transfected with T-bet HDV (Figure S5D).
However, STAT1 inhibition did not affect the expression of
CD40L, ICOS, or IL-21 (Figure S5E). These results show that
the promotion of CXCR5 and the downregulation of CD40L,
ICOS, and IL-21 by T-bet were independent of STAT1 signals.
IRF4 Inhibits the Development of Eomes+ Th1 Cells
IRF4 is a TF expressed by various CD4+ T cell subsets (Huber
and Lohoff, 2014). IRF4 is important for Tfh cell differentiation,
because IRF4-deficient CD4+ T cells display an impaired ability
to differentiate into Tfh cells in mice (Bollig et al., 2012; Kwon
et al., 2009). However, little is known regarding the mechanism
by which IRF4 contributes to Tfh differentiation. In humans,
IRF4 expression by tonsillar Tfh precursors and GC Tfh cells is
comparable to that of naive CD4+ T cells (Schmitt et al., 2014).(C) T-bet ChIP assay. T-bet binds to IL21 andCD40LG genes. IGX1 andMYOD1were used as negative contro
SEM, n = 4.
(D) T-bet siRNA transfection enhances the ability of IL-12-stimulated CD4+ T cells to help B cells. ActivatedCD
cultured with or without IL-12 for 72 hr. Sorted FSChiSSChi cells were co-cultured with autologous memory
cultured B cells was analyzed at day 14. The number of recovered B cells per culture well is indicated in red
(E) T-bet HDV transfection abolishes the ability of IL-12-stimulated CD4+ T cells to help B cells. Activated CD
culturedwith or without IL-12 for 72 hr. SortedmCD24+CD4+ T cells were co-culturedwith autologousmemory
at day 14. Representative of three experiments.
1090 Cell Reports 16, 1082–1095, July 26, 2016Therefore, we hypothesized that IRF4
might play an important role during the
early stages of Tfh cell differentiation in
humans.
Consistent with previous studies in
mice (Man et al., 2013; Nayar et al.,
2012), stimulation with anti-CD3 and
CD28 rapidly upregulated IRF4 expres-sion by human naive CD4+ T cells (Figure 1D). IL-12 stimulation
did not largely modulate IRF4 expression (Figure 1D). To deter-
mine how IRF4 affects the phenotype and gene profiles of IL-
12-stimulated human CD4+ T cells, we transfected IRF4 siRNA,
which resulted in decreased expression of IRF4 protein by
more than 60% for at least 48 hr after transfection (Figure S6A).
However, the inhibitory effect became negligible at 72 hr post-
transfection, particularly in IL-12-stimulated CD4+ T cells (Fig-
ure S6A). Transfection of IRF4 siRNA did not alter cell recovery
or viability in our experiments (Figure S6B). Nonetheless, despite
a short-lived effect, IRF4 inhibition significantly decreased the
expression of CXCR5, ICOS, IL-21, and Bcl-6 by IL-12-stimu-
lated CD4+ T cells (Figures 7A and 7B). Transcript analysis
by Nanostring showed that IRF4 inhibition resulted in a dimin-
ished Tfh gene signature by IL-12-stimulated CD4+ T cells and
thus in decreased BCL6, BATF, CXCR5, ICOS, and PDCD1
and increased PRDM1 and FOSL2 (Figure 7C).
In contrast, IRF4 inhibition substantially increased IFN-g
expression by IL-12-stimulated CD4+ T cells (Figures 7A and
7B). This was not due to an increase of T-bet, because IRF4 in-
hibition decreased T-bet expression by IL-12-stimulated CD4+
T cells (Figure 7B). Instead, IRF4 inhibition induced a marked
increase of Eomesodermin (Eomes) transcript (Figure 7D) and
protein (Figure 7E), a TF important for IFN-g production byls, and IFNGwas used as a positive control. Mean ±
4+ T cells transfected with the indicated siRNAwere
B cells in the presence of SEB. The phenotype of
. Representative of three experiments.
4+ T cells transfected with the indicated HDV were
B cells, and the phenotype of B cells was analyzed
BC
D
A
E
F
(legend on next page)
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CD8+ T cells (Pearce et al., 2003). Eomes+ CD4+ T cells induced
by IL-12 stimulation after IRF4 siRNA transfection co-expressed
T-bet and IFN-g. In contrast, Eomes+ CD4+ T cells poorly ex-
pressed CXCR5 and Bcl-6 (Figure 7E). A fraction of Eomes+
CD4+ T cells expressed IL-21, but this was limited to those ex-
pressing Eomes at low levels.
Lastly, to determine whether IRF4 inhibition affects the helper
functions, IRF4 siRNA-transfected CD4+ T cells were cultured
with B cells. The B cells cultured with IL-12-stimulated CD4+
T cells transfected with IRF4 siRNA produced fewer Igs than
those cultured with CD4+ T cells transfected with control siRNA
(Figure 7F; Figure S6C). These results suggest that IRF4 plays
important roles to tip the balance of the differentiation of IL-12-
stimulated CD4+ T cells toward the Tfh lineage in humans. While
IRF4 promotes the expression of Tfh molecules, IRF4 inhibits the
generation of Eomes+ Th1 cells.
DISCUSSION
Human CXCR5+ CD4+ T cells generated by IL-12 stimulation
expressed both Tfh molecules (CD40L, ICOS, IL-21, Batf, and
Bcl-6) and Th1 molecules (IFN-g and T-bet). Therefore, as
demonstrated in mice (Nakayamada et al., 2011; Pepper et al.,
2011), these CXCR5+ CD4+ T cells appear to be endowed with
the ability to differentiate into both Tfh and Th1 cells. Our current
study shows mechanisms that control their differentiation and
functions.
Mouse studies suggested that the balance between T-bet and
Bcl-6 largely regulates the differentiation of CD4+ T cells into
either the Th1 cell lineage or the Tfh cell lineage (Weinmann,
2014). However, our study suggests that T-bet does not strongly
inhibit Tfh cell differentiation programs per se in humans. While
T-bet bound to human BCL6 and PRDM1 genes (also shown
by sequencing data) (Figure S7), T-bet inhibition or overexpres-
sion did not strongly affect the expression of Bcl-6 or Blimp-1
proteins in IL-12-stimulated CD4+ T cells. Furthermore, T-bet
expression by human CD4+ T cells in response to stimulation
via CD3 and CD28 and by IL-12 stimulation seems transient;
therefore, the time window within which T-bet inhibits Bcl-6
function by masking its DNA-binding domain (Oestreich et al.,
2012) seems narrow. Rather, we found that T-bet overexpres-
sion promoted CXCR5 expression by human CD4+ T cells.
T-bet also downregulated the expression of CCR7 and EBI2 by
human CD4+ T cells. Therefore, our results suggest that T-bet
might contribute to some extent to human Tfh cell differentiationFigure 7. IRF4 Regulates the Expression of Tfh and Th1 Molecules by
(A and B) Expression of ICOS, CXCR5, IFN-g, IL-21 (cytokines after PMA and ion
CD4+ T cells after 48 hr stimulationwith IL-12. Gated to FSChiSSChi activated cells
Bcl-6 and T-bet, n = 13. Paired t test, **p < 0.01, ***p < 0.001.
(C) Gene profiling of activated naive CD4+ T cells transfected with either IRF4 siRN
siRNA-transfected CD4+ T cells were normalized to those in control siRNA-trans
(D) Eomes transcript expression by activated naive CD4+ T cells transfected with
n = 3. One-way ANOVA among the group with or without IL-12 stimulation. ***p
(E) Expression of Eomes and other Th1 and Tfh molecules. The phenotype of the IL
three experiments.
(F) IRF4 siRNA transfection decreases helper functions. Activated CD4+ T cells tra
72 hr. Sorted FSChiSSChi cells were co-cultured with autologous memory B cells
day 14. Data from quadruplicate wells in a representative experiment (n = 3).
1092 Cell Reports 16, 1082–1095, July 26, 2016at early stages by promoting the acquisition of the phenotype
required for migration toward B cell follicles and for retention
within follicles.
In contrast, T-bet downregulated the expression of Tfh func-
tional molecules, CD40L, ICOS, and IL-21; accordingly, T-bet
overexpression abrogated the helper function of IL-12-stimu-
lated CD4+ T cells. Thus, T-bet seems more involved in the
downregulation of the helper functions than in the differentiation
of Tfh cells in humans. This hypothesis is supported by the fact
that among blood cTfh cells in humans, the subset expressing
T-bet (which expresses the chemokine receptor CXCR3) is the
least efficient at providing help to B cells (Locci et al., 2013; Mor-
ita et al., 2011). Even when CXCR3+ cTfh cells provide help to B
cells, for example, after split-virus seasonal influenza vaccina-
tion, their helper activity seems limited to memory B cells and
does not help naive B cells, partly because of limited expression
of IL-21 (Bentebibel et al., 2013). Overall, these observations
suggest that T-bet expressed by human Tfh lineage cells might
act as a rheostat, regulating their helper capacities.
Our study also showed that IRF4 plays an important role in
the regulation of the differentiation of IL-12-stimulated CD4+
T cells. IRF4 was rapidly induced in response to CD3 and
CD28 stimulation but was not largely affected by IL-12 stimula-
tion. Despite a short-lived effect, IRF4 siRNA transfection signif-
icantly decreased the expression of Tfh molecules, including
CXCR5, IL-21, ICOS, and Bcl-6, by IL-12-stimulated CD4+
T cells. In contrast, IRF4 siRNA transfection increased their
IFN-g expression. Furthermore, IRF4 siRNA transfection
decreased the helper capacity of IL-12-stimulated CD4+
T cells. These observations suggest that IRF4 tips the balance
of IL-12-stimulated CD4+ T cell differentiation toward the Tfh
cell and away from the Th1 cell.
While both T-bet and IRF4 are rapidly induced in response to
CD3 and CD28 stimulation (Figure 1D), enhanced IFN-g expres-
sion by IRF4 inhibition was not due to increased T-bet expres-
sion. T-bet overexpression by HDV transfection also did not
affect IRF4 expression (data not shown). Therefore, the expres-
sion of T-bet and IRF4 might be independently regulated in hu-
man CD4+ T cells, and these two molecules may not directly
affect each other. Instead, we found that IRF4 inhibition induced
a marked induction of Eomes, an IFN-g-promoting TF typically
expressed by activated CD8+ T cells. Previous studies show
that CD3 stimulation is sufficient to induce robust expression
of Eomes in CD8+ T cells but not CD4+ T cells (Pearce et al.,
2003). Consistently, we did not observe substantial EomesIL-12-Stimulated CD4+ T Cells
omycin re-stimulation), T-bet, and Bcl-6 by activated IRF4 siRNA-transfected
. (A) A representative result. (B) CXCR5 and ICOS, n = 8; IFN-g and IL-21, n = 13;
A or control siRNA and stimulated with IL-12 for 48 hr. Transcript counts in IRF4
fected CD4+ T cells in each donor. Results from three donors are shown.
the indicated siRNA and stimulated with or without IL-12 for 48 hr. Mean ± SD,
< 0.001.
-12-stimulated CD4+ T cells cultured as in (A) was analyzed. Representative of
nsfected with IRF4 siRNAwere cultured in the presence or absence of IL-12 for
in the presence of SEB. IgG produced in the cultures was analyzed by ELISA at
expression by human naive CD4+ T cells stimulated with anti-
CD3 and CD28 even in the presence of IL-12. Eomes expression
became evident only when IRF4 was inhibited in IL-12-stimu-
lated CD4+ T cells. This is consistent with a previous observation
in mCD8+ T cells that IRF4 downregulates Eomes expression
(Nayar et al., 2012). Furthermore, Eomes+ CD4+ T cells induced
by IRF4 inhibition highly expressed the Th1 molecules IFN-g and
T-bet but poorly expressed the Tfhmolecules CXCR5, IL-21, and
Bcl-6. These observations suggest that IRF4 plays an important
role in inhibiting Th1 cell differentiation by suppressing Eomes.
Given that the expression of IRF4 by CD4+ T cells is in proportion
to the strength of signals via T cell receptors (Man et al., 2013),
strong IRF4 expression might be one of the mechanisms by
which high-affinity T cells preferentially differentiate into the Tfh
lineage (Fazilleau et al., 2009; Tubo and Jenkins, 2014).
In conclusion, our study shows that the differentiation and the
function of developing human Tfh cells are regulated by multiple
TFs. While T-bet regulates the helper function of developing Tfh
cells, IRF4 tips the balance of Th1 versus Tfh cell differentiation
toward the Tfh lineage. Our study provides novel insights into
vaccine designs and therapeutic approaches for human autoim-
mune diseases. We surmise that vaccines that preferentially
induce T-bet Tfh cells will be more effective than those that
preferentially induce T-bet+ Tfh cells for efficient Ab responses.
In autoimmune diseases, correction of the cTfh subset balance
from T-bet dominant to T-bet+ dominant might be beneficial
for treatment by decreasing the number of functional Tfh cells
and thus limiting the generation of autoantibodies.
EXPERIMENTAL PROCEDURES
Isolation and Culture of CD4+ T Cells
The study was approved by the Institutional Review Board of Baylor Research
Institute. Naive CD4+ T cells were purified as described previously (Schmitt
et al., 2014) and were stimulated overnight with CD3-CD28 Dynabeads
(Invitrogen) in RPMI complete medium supplemented with 10% fetal calf
serum. After overnight stimulation, naive CD4+ T cells were transfected with
siRNA, transduced with HDV, or directly cultured in flat-bottomed 96-well
plates coated with CD3 mAb (5 mg/ml, OKT3) in the presence of soluble
CD28 mAb (1 mg/ml, CD28.2).
siRNA Transfection
Naive CD4+ T cells were transfected with siRNA using the Human T cell
Nucleofector Kit and Nucleofector II device (Amaxa) according to manufac-
turer’s instructions. The siRNA to target TBX21 (s26889), STAT1 (s277),
STAT4 (s13531), IRF4 (s223947), and silencer select negative control #1 siRNA
(Ambion) was used at 5 mM (0.5 nmol/5 3 106 cells in each transfection). Cells
were transferred at 6 hr post-transfection to flat-bottomed 96-well plates
coated with CD3 mAb and supplemented with soluble CD28 mAb. IL-12
(1 ng/ml) was added to the culture at 24 hr post-transfection.
HDV Production and Transduction
HDV-expressing human T-bet and the mCD24 reporter gene and control
vector were obtained fromDr. Derya Unutmaz (Sundrud et al., 2003). Lentivirus
was produced by transfecting 293T cells with HDV and vesicular stomatitis
virus-G plasmids. The virus-containing supernatants were collected at 48
and 72 hr post-transfection and passed through a 0.45 mm filter. The virus
preparation was then concentrated with an Amicon Ultra 100 kDa filter and
stored at 80C. Naive CD4+ T cells were plated in flat-bottomed 96-well
plates coated with CD3 mAb and transduced at a 5–10 moi. The transduction
efficiency was increased by spinning at 1,200 g for 2 hr at room temperature.
Soluble CD28 mAb and IL-12 were then added to the culture.T-B Co-culture Assay
B cells were enriched from apheresis peripheral blood mononuculear
cells (PBMCs) by positive selection using CD19 MicroBeads and LS column
(Miltenyi). Memory B cells were sorted with FACSAria as CD27+ CD3
CD11c CD14 cells after staining with CD27 PE (L128), CD3 APC (SK7),
CD11c APC (S-HCL-3), and CD14 APC (T€uK4) mAbs. Cell purity was >98%.
For the T-B co-culture experiment, activated FSChiSSChi (forward
scatterhiside scatterhi) cells (siRNA transfection experiments) or activated
mCD24+ cells (HDV experiments) were sorted after 72 hr stimulation with or
without IL-12 and were co-cultured with autologous memory B cells (5 3
103 T cells for 40 3 103 memory B cells per well) in 96-well flat-bottom plates
in Yssel medium/10% fetal bovine serum in the presence of endotoxin-
reduced staphylococcal enterotoxin B (SEB) (0.25 ng/ml; Toxin Technology).
Igs (IgM, IgG, and IgA) produced in the cultures were analyzed by ELISA at
day 14. The phenotype of B cells was assessed by flow cytometry. Co-cultured
T and B cells were incubated with LIVE/DEAD fixable Aqua and CD3 (UCHT1),
CD4 (RPA-T4), CD19 (J3-119), CD20 (2H7), CD38 HB7), and CD138 (MI15)
mAbs before being acquired on a BD LSRII.
Statistics
The significance of the difference between groups in the experiments was
evaluated by two-tailed paired t test or One-way ANOVA test. A value of
p < 0.05 was considered significant.
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